可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Ling S,Dai A, Dilley RJ,et al.Endogenous estrogen deficiency reduces proliferation and enhances apoptosisrelated death in vascular smooth muscle cells: insights from the aromataseknockout mouse[J]. Circulation,2004,109(4): 537-543.
[2] Yue TL,VickeryClark L,Louden CS,et al.Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization,and inhibits neointimal formation In vivo after vascular injury[J]. Circulation,2000,102(19 suppl 3):III281-III288.
[3] Li J,Huang SL,Guo ZG.Plateletderived growth factor stimulated vascular smooth muscle cell proliferation and its molecular mechanism[J]. Acta Pharmacol Sin,2000,21(4): 340-344.
[4] Worboys S,Kotsopoulos D, Teede H,et al.Evidence that parenteral testosterone therapy may improve endotheliumdependent and independent vasodilation in postmenopausal women already receiving estrogen[J]. Clin Endocrinol Metab,2001,86(1): 158-161.
[5] Sudoh N, Toba K, Akishita M,et al.Estrogen prevents oxidative stress–induced endothelial cell apoptosis in rat[J]. Circulation,2001,103(5):724-729.
[6] Strehlow K, Rotter S, Wassmann S,et al.Modulation of antioxidant enzyme expression and function by estrogen [J]. Circ Res,2003,93(2): 170-177.
[7] Liu HW,Iwai M,TakedaMatsubara Y,et al.Effect of estrogen and AT1 receptor blocker on neointima formation[J]. Hypertension,2002,40(4): 451-457.
[8] Hodgin JB,Knowles JW, Kim HS,et al.Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice[J]. Clin Invest,2002,109(4): 541-548.